BDX Q2 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.8B+1.5% YoY

Gross Profit

$2.2B46.4% margin

Operating Income

$628M13.0% margin

Net Income

$460M9.5% margin

EPS (Diluted)

$1.53

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

$184M

Free Cash Flow

$3M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$54.4B

Total Liabilities

$28.7B

Stockholders' Equity

$25.7B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$4.8B	+1.5%
Gross Profit	$2.2B	$2.1B	+5.8%
Operating Income	$628M	$564M	+11.3%
Net Income	$460M	$454M	+1.3%

Revenue Segments

Medical

$2.4B49%

Life Sciences

$1.3B26%

Interventional

$1.2B25%

Geographic Segments

UNITED STATES

$2.7B57%

Non-US

$2.1B43%